MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Precipio ROA Ratio 2011-2026 | PRPO
Annual ROA Ratio Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.7 | -25.24 | -32.34 | -56.63 | -27.98 | -51.3 | -67.87 | -72.64 | -75.91 | -604.92 | -684.26 | -46.46 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.7 | -684.26 | -145.61 |
Quarterly ROA Ratio Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.64 | -11.96 | -19.4 | -23.24 | -30.88 | -34.82 | -39.56 | -35.01 | -48.49 | -54.33 | -50.78 | -38.09 | -43.96 | -36.35 | -37.1 | -21.95 | -37.84 | -47.87 | -49.67 | -42.14 | -51.87 | -45.69 | -65.22 | -48.5 | -66.31 | -74.4 | -57.2 | -42.21 | -65.25 | -70.47 | -70.86 | -39.32 | -98.58 | -134.81 | -174.04 | -371.25 | -522.81 | -615.1 | -630.37 | -282.7 | -302.01 | -150.72 | -129.18 | -112.5 | -106.35 | -158.88 | -165.22 | -171.55 | -164.37 | -133.03 | -81.68 | -35.83 | -29.08 | -11.4 | -27.82 | -29.15 | -3.78 | -17.87 | -8.28 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -3.78 | -630.37 | -103.01 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 117.79 | 3.44 % | $ 35.8 B | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 25.76 | 3.75 % | $ 716 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Danaher Corporation
DHR
|
4.33 | $ 197.13 | 3.2 % | $ 140 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.46 | 3.46 % | $ 498 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 18.77 | 6.23 % | $ 1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
-20.67 | $ 98.12 | 5.17 % | $ 12.3 B | USA |
 |
DexCom
DXCM
|
13.19 | $ 65.04 | 3.05 % | $ 25.4 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.49 | 2.49 % | $ 177 M |  China |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 111.47 | 4.02 % | $ 9.19 B |  Irlanda |
 |
Illumina
ILMN
|
-19.4 | $ 131.01 | 3.61 % | $ 20.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
IQVIA Holdings
IQV
|
4.54 | $ 175.27 | 2.78 % | $ 30.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 272.99 | 1.42 % | $ 22.7 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 79.33 | 1.6 % | $ 5.35 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 178.81 | 5.42 % | $ 8.86 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 522.44 | 2.74 % | $ 15.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K |  Israel |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 314.35 | 3.49 % | $ 27.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.91 | 3.61 % | $ 455 M | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.46 | 4.96 % | $ 1.08 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 14.78 | 1.69 % | $ 1.92 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 10.59 | 6.06 % | $ 2.3 B | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 217.44 | 3.9 % | $ 21.4 B | USA |
 |
Pacific Biosciences of California
PACB
|
-69.68 | $ 1.53 | 6.25 % | $ 459 M | USA |
 |
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | USA |
 |
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Personalis
PSNL
|
-30.08 | $ 6.72 | 8.91 % | $ 398 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-67.95 | $ 2.72 | 1.12 % | $ 88.3 K | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.18 | 0.93 % | $ 5.01 M | USA |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.16 | -0.85 % | $ 6.32 M | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 2.0 | 1.27 % | $ 8.85 M | USA |